Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.

@article{Burkhardt2006CytoplasmicOO,
  title={Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.},
  author={Mick Burkhardt and Empar Mayordomo and K. J. Winzer and Florian Fritzsche and Tserenchunt Gansukh and Stefan Pahl and Wilko Weichert and Carsten Denkert and Hans Guski and Manfred Dietel and Glen Kristiansen},
  journal={Journal of clinical pathology},
  year={2006},
  volume={59 4},
  pages={403-9}
}
BACKGROUND Activated leucocyte cell adhesion molecule (ALCAM, CD166) is a cell surface member of the immunoglobulin superfamily. ALCAM expression has prognostic relevance in prostate and colon cancer. OBJECTIVE To evaluate ALCAM protein expression in breast cancer by immunohistochemistry and to correlate expression levels with clinicopathological data… CONTINUE READING